Pro Medicus Limited (ASX:PME) is a healthcare informatics company providing medical imaging software and services to hospitals, imaging centres and healthcare groups worldwide. Its Visage 7 platform remains central to the company’s 2026 expansion across large health systems, particularly in North America, where cloud-based …
Medibank Private Limited (ASX:MPL) is an Australian health company that provides private health insurance and health-related services through brands including Medibank and ahm. In 2026, the group is continuing to develop preventative health, virtual care and alternative clinical pathways as part of a broader …
Ramsay Health Care Limited (ASX:RHC) operates private hospitals and healthcare services across Australia and selected international markets. In 2026, the group’s focus is on reshaping parts of its European operations while improving capacity utilisation, clinical productivity and service delivery across its Australian hospital network.
Sonic Healthcare Limited (ASX:SHL) is one of the world’s largest medical diagnostics companies, providing laboratory medicine and diagnostic imaging services to medical practitioners, hospitals, community health services and patients. During FY2026, the group’s operating agenda centred on integrating acquired laboratory networks, capturing efficiencies in …
CSL Limited (ASX:CSL) is a global biotechnology company with operations spanning therapies for serious and rare diseases. CSL shares were quoted at A$176.92 on 5 October 2026. Its latest announcement adds lixudebart to the company’s development pipeline through an exclusive co-development and co-promotion agreement …
Dimerix Limited (ASX:DXB) is a clinical-stage biopharmaceutical company developing therapies for kidney diseases with significant unmet medical need. DXB shares were quoted at A$0.24 on 5 October 2026. Its lead program, DMX-200, is in Phase 3 development for focal segmental glomerulosclerosis, or FSGS, while …
CSL Limited (ASX:CSL) is a global biotechnology company developing and delivering medicines for serious and complex diseases, including plasma-derived therapies, vaccines, and treatments in iron deficiency and nephrology. In 2026, a key operational theme is how the group is improving plasma collection and manufacturing …
Dimerix Limited (ASX:DXB) has recorded a long-duration milestone in its DMX-200 program, with the first patient completing two years in the ACTION3 Phase 3 study followed by another two years in its open-label extension. The four-year participation period adds a new layer of long-term …
On 2 October 2026, Medibank shares were trading at $4.57, up 1.33% for the session. The company's 2026 full-year results, released in August, reported growth in underlying profit, policyholders and health services, along with a higher ordinary dividend.
On 2 October 2026, Ramsay shares were trading at $53.92, down 1.03% for the session. The company's full-year results, released in August, reported higher underlyingEarningsacross all regions, a higherDividendand progress toward the proposed separation of Ramsay Santé.